Can you get medical cannabis for Tourette syndrome in the UK?

Tourette syndrome and other chronic tic disorders are among the conditions UK private specialists consider. The evidence is small but, unusually for this field, includes recent randomised trials — and the results are genuinely mixed rather than simply absent.

Is Tourette syndrome treated with medical cannabis in the UK?

It is assessed privately, typically in adults with severe tics that have not responded adequately to behavioural therapy and to the medicines normally used. There is no licensed cannabis-based medicine for tic disorders in the UK and no NHS route for this use.

UK practice puts behavioural treatment first: comprehensive behavioural intervention for tics, habit reversal training, or exposure and response prevention. These have the strongest evidence in Tourette syndrome and are recommended ahead of medication. Where medicines are used, they are usually antipsychotics such as aripiprazole or risperidone, or clonidine — all of which carry their own significant side effects, which is part of why alternatives get asked about.

Tourette syndrome rarely travels alone. Obsessive-compulsive symptoms, ADHD, anxiety and sleep problems are common, and often account for more of the day-to-day difficulty than the tics. A good assessment addresses those directly rather than treating them as background.

What the evidence actually shows

Tourette syndrome has better trial evidence than most conditions on this site, and the trials do not all point the same way. That is worth knowing before you read a clinic's summary of them.

A randomised double-blind crossover trial published in NEJM Evidence gave adults with severe Tourette syndrome six weeks of an oral oil containing THC and CBD and six weeks of placebo, separated by a washout, measuring total tic score on the Yale Global Tic Severity Scale. It found a reduction in tic severity during the active phase, alongside evidence of benefit for co-occurring obsessive-compulsive and anxiety symptoms. A separate large German trial of a THC:CBD spray in chronic tic disorders did not meet its primary endpoint.

The fair reading is: a real signal, small studies, inconsistent results, and no basis yet for treating this as established. Cannabidiol alone does not appear to be the active ingredient in tic reduction; where effects are seen, THC is involved, which brings the cognitive side effects with it.

What a specialist will want to see

There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For Tourette syndrome they will typically look at:

• When the tics began, how severe they are now, and how they affect work, study and daily life
• Whether you have had behavioural therapy — habit reversal or exposure and response prevention — and what happened
• Which medicines you have tried, including antipsychotics and clonidine, and why they were stopped
• Co-occurring OCD, ADHD, anxiety or depression, and how each is being treated
• Your age: tics often peak in adolescence and improve in adulthood, which affects how a trial is interpreted
• Your personal and family history of psychosis, and your current mental health

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks and reasons a specialist may say no

The main trade-off in Tourette syndrome is cognitive. THC can impair concentration and memory, which is a real cost for people who are working or studying — and often the same people whose tics are most disruptive.

Anxiety can worsen with THC in some people, which matters given how often anxiety accompanies Tourette syndrome. A personal or family history of psychosis weighs heavily against treatment. Because tics naturally wax and wane, and often improve from adolescence into adulthood, a specialist should build a review point into any trial rather than attributing every good period to the medicine.

How medical cannabis is thought to help

Cannabis-based medicines act on the endocannabinoid system, a signalling network found throughout the brain, nervous system and immune cells that helps regulate movement, mood, anxiety and sleep. That broad role is why these medicines are studied across such different conditions — but a plausible mechanism is not the same as proven benefit, and in Tourette syndrome the evidence remains small and mixed.

The two most studied plant compounds behave very differently. THC is intoxicating and acts directly on cannabinoid receptors; cannabidiol (CBD) is not intoxicating and works more indirectly. Where a reduction in tics has been seen in trials, THC appears to be involved rather than CBD alone — which means the potential benefit comes bundled with THC's cognitive effects. Our guides on the endocannabinoid system and THC and CBD explain the difference in more detail.

Tics themselves wax and wane, and the urge that precedes them may respond to relaxation and reduced anxiety as much as to any direct effect on the tic. That makes it genuinely hard to judge benefit, and is one reason a structured trial with a clear review point matters.

What treatment involves in practice

No cannabis-based medicine is licensed for tic disorders, so any treatment here is unlicensed and carried on specialist responsibility with your informed consent. If a specialist decides a monitored trial is justified, it starts at a low dose and is increased slowly — titrated — while benefit is weighed against side effects.

Products are usually oils or capsules taken by mouth, which act more slowly and last longer, or dried flower for vaporising, which acts faster; smoking is never a medical route. In Tourette syndrome the cognitive cost of THC is weighed carefully, especially for people who are working or studying. How the format and dose are chosen is set out in how a dose is decided and adjusted and how cannabis-based medicines are taken.

Follow-up reviews check how you are responding and whether side effects are tolerable, and the plan is adjusted — or stopped — accordingly. Because tics naturally fluctuate, benefit is judged over weeks rather than a single good day, as how long cannabis medicines take to work explains. Behavioural therapy remains the first-line treatment throughout, not something a prescription replaces.

Questions worth asking your specialist

A good assessment is a two-way conversation. Whether treatment turns out to suit you or not, these are sensible questions to bring, alongside the practical guides on driving, work and drug testing, and travelling abroad:

• Have I had proper access to behavioural therapy, and is it reasonable to consider medication now?
• Given that any benefit likely involves THC, how will we manage the effect on concentration?
• How will this fit with treatment for my OCD, ADHD or anxiety, if I have them?
• How will we tell a real effect apart from the natural waxing and waning of tics?
• At what point would we agree the treatment is not helping and stop it?

If you want to take this further

The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If Tourette syndrome is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Patient guide · Written by the Flora House editorial team · Last reviewed: 7 October 2026